Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population
- PMID: 2751755
- DOI: 10.1016/0021-9150(89)90086-5
Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population
Abstract
The association of restriction fragment length polymorphism genetic markers at the apolipoprotein AI-CIII-AIV gene locus with lipid and lipoprotein levels was evaluated in subsets of the 666 Caucasian students from the junior high school (11-14 years old) population of Muscatine, Iowa. Male students whose leukocyte DNA had an uncommon haplotype consisting of the minor allele of a SacI restriction site polymorphism (S2) in combination with the more common allele of an MspI site variation (M1) had significantly lower levels of high density lipoprotein (HDL)-cholesterol (P less than 0.05) when compared to a random sample of males; these levels were stable over a 2-year follow-up. The minor allele of an XmnI restriction site polymorphism (X2) was more frequent in females with triglyceride levels in the upper decile of the age and gender-specific triglyceride distribution than in normotriglyceridemic females (0.10 less than P less than 0.15) and triglyceride levels were higher in random sample females with an X2 allele than in X1 homozygotes (P less than 0.10). These results suggest that alleles of the known apolipoprotein genes (AI, CIII, AIV) at this locus or closely linked gene sequences may have major effects on lipid levels in members of the general population.
Similar articles
-
Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.Atherosclerosis. 1993 May;100(2):157-69. doi: 10.1016/0021-9150(93)90202-6. Atherosclerosis. 1993. PMID: 8102848
-
Genetic markers associated with high density lipoprotein cholesterol levels in a biracial population sample.Genet Epidemiol. 1992;9(2):109-21. doi: 10.1002/gepi.1370090204. Genet Epidemiol. 1992. PMID: 1639243
-
Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.Atherosclerosis. 1989 Jul;78(1):9-18. doi: 10.1016/0021-9150(89)90153-6. Atherosclerosis. 1989. PMID: 2569310
-
[Connection of polymorphic alleles of the gene cluster AI/CIII/AIV with disturbed lipid metabolism].Mol Biol (Mosk). 1994 Jan-Feb;28(1):216-23. Mol Biol (Mosk). 1994. PMID: 8145752 Russian.
-
Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.Eur J Intern Med. 2011 Aug;22(4):407-11. doi: 10.1016/j.ejim.2011.03.002. Epub 2011 Apr 21. Eur J Intern Med. 2011. PMID: 21767760
Cited by
-
Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.Hum Genet. 1992 Feb;88(4):439-46. doi: 10.1007/BF00215679. Hum Genet. 1992. PMID: 1740321
-
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.Acta Diabetol. 1995 Dec;32(4):251-6. doi: 10.1007/BF00576258. Acta Diabetol. 1995. PMID: 8750764
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical